Dada, O., Olufemi, D & John, A (2020). Intravenous Ascorbic Acid (IVAA) for COVID-19 Supportive Treatment in Hospitalized COVID-19 Patients (Based on use in China and US settings). Afribary. Retrieved from https://tracking.afribary.com/works/ivaa-covid19-hospital-use-anderson-03-24-2020
Dada, Olufemi, et. al. "Intravenous Ascorbic Acid (IVAA) for COVID-19 Supportive Treatment in Hospitalized COVID-19 Patients (Based on use in China and US settings)" Afribary. Afribary, 02 Jul. 2020, https://tracking.afribary.com/works/ivaa-covid19-hospital-use-anderson-03-24-2020. Accessed 12 Nov. 2024.
Dada, Olufemi, Dada Olufemi and Adeyanju John . "Intravenous Ascorbic Acid (IVAA) for COVID-19 Supportive Treatment in Hospitalized COVID-19 Patients (Based on use in China and US settings)". Afribary, Afribary, 02 Jul. 2020. Web. 12 Nov. 2024. < https://tracking.afribary.com/works/ivaa-covid19-hospital-use-anderson-03-24-2020 >.
Dada, Olufemi, Dada Olufemi and Adeyanju John . "Intravenous Ascorbic Acid (IVAA) for COVID-19 Supportive Treatment in Hospitalized COVID-19 Patients (Based on use in China and US settings)" Afribary (2020). Accessed November 12, 2024. https://tracking.afribary.com/works/ivaa-covid19-hospital-use-anderson-03-24-2020